Nanostream, Inc. (Pasadena, California), a developer of microfluidics-based parallel HPLC technology and a provider of assay development has closed all business operations.
Nanostream, Inc. (Pasadena, California), a developer of microfluidics-based parallel HPLC technology and a provider of assay development has closed all business operations. The company, reportedly stopped business on March 14th and has listed its intellectual property for sale on the company website.
Advancing Bladder Cancer Research with Mass Spectrometry: A FeMS Interview with Marta Relvas-Santos
November 12th 2024LCGC International interviewed FeMS Empowerment Award winner Marta Relvas-Santos on her use of mass spectrometry to identify potential biomarkers and therapies for bladder cancer. She also shared insights on her work with FeMS and advice for fellow scientists.
Exploring The Chemical Subspace of RPLC: A Data-driven Approach
November 11th 2024Saer Samanipour from the Van ‘t Hoff Institute for Molecular Sciences (HIMS) at the University of Amsterdam spoke to LCGC International about the benefits of a data-driven reversed-phase liquid chromatography (RPLC) approach his team developed.